Anavex Life Sciences Corp (AVXL)

[camk]

When discussing valuations, it seems everyone is focused solely on AD. I challenge everyone to evaluate SRPT and their market cap who has a drug for the rare disease DMD. Look at their trials to include population size. My point is if the Rett and/or PDD short trials yield positive results, AVXL market cap will race beyond $2B ( which with say 50M shares out would be $40 )

2019 is go time